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ABSTRACT 
 
Racemic and enantiomerically pure β-amino-α-trifluoromethyl alcohols were obtained 
via sequential nucleophilic trifluoromethylation of selected α-imino ketones, derived 
from arylglyoxals, and subsequent removal of the MeO or Ph(Me)CH substituent, 
respectively, located at the N-atom. The obtained products, containing a primary amino 
group, were used for the synthesis of imidazole N-oxides bearing a trifluoromethyl 
group as a part of the N(1)-alkyl chain. Imidazole N-oxides with an electron-
withdrawing ester group at C(4) underwent spontaneous isomerization under the 
reaction conditions, and the corresponding imidazol-2-one derivatives were isolated as 
final products.  
 
1. Introduction 
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The importance of β-amino-α-trifluoromethyl alcohols is well established, and our 
recent review summarizes methods of their synthesis as well as applications for the 
preparation of heterocycles and biologically active compounds [1]. The elaboration of 
simple and efficient methods for their synthesis is a challenging task. Particular 
attention is focused on amino compounds, which contain the trifluoromethyl group in α-
position [2]. Very likely, the same relationship is valid for trifluoromethylated 
imidazole derivatives, with the CF3 group attached directly to C(2) [3] of the imidazole 
ring or in a side chain attached to N(1) [4]. 
Regioselective nucleophilic trifluoromethylation of imines 1 derived from arylglyoxals 
with subsequent reduction of the C=N bond was described as a convenient protocol for 
the preparation of β-amino-α-trifluoromethyl alcohols 2 with a secondary amino group 
[5] (Scheme 1). These products were applied for the preparation of aziridines as well as 
five- and six-membered O,N-heterocycles [6]. 
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Scheme 1 
 
The synthesis and reactivity of 2-unsubstituted imidazole N-oxides 3 are of current 
interest as they are useful building blocks for the preparation of diverse imidazole 
derivatives, including enantiomerically pure compounds [7]. The straightforward 
method for their synthesis is based on the condensation of α-hydroxyimino ketones 4 
with formaldehyde and a corresponding primary amine (Scheme 2). 
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In a previous paper, we showed that the primary amine can be replaced by a β-amino 
alcohol and the imidazole N-oxide obtained in this case contains a β-hydroxyalkyl 
residue at N(1) [7e]. 
The goal of present study was the elaboration of a method for the preparation of amino 
alcohols of type 2 with a primary amino group (R = H) via nucleophilic 
trifluoromethylation [8] of properly selected arylglyoxalimines. Furthermore, the 
obtained β-amino-α-trifluoromethyl alcohols should be used as starting materials for the 
synthesis of new imidazole N-oxides 3, bearing a β-hydroxy-β-trifluoromethyl 
substituent at N(1). Moreover, optically active imidazole N-oxides with this substitution 
pattern should be also prepared. 
 
2. Results and discussion 
 
Searching for suitably substituted arylglyoxalimines, the model compounds 6, bearing a 
methoxy group at the N-atom, were selected. They were obtained by treatment of 
arylglyoxal hydrates 5a,b with O-methyl hydroxylamine hydrochloride in the presence 
of sodium acetate. The subsequent nucleophilic trifluoromethylation was carried out 
under typical conditions using an equimolar amount of CF3SiMe3 (Ruppert-Prakash 
reagent [8]) in dimethoxyethane (DME) in the presence of catalytic amounts of CsF. 
The crude reaction mixtures were examined by 19F-NMR spectroscopy, which 
evidenced the presence of only one CF3 signal in each case. Additionally, the IR and 
13C-NMR spectra indicated that the obtained products contained still the C=N bond, in 
accordance with the structure of the O-silylated 1:1 adducts 7 (Scheme 3). 
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The attempted desilylation/reduction step using NaBH4 [5] led in both cases to complex 
mixtures. The alternative protocol with LiAlH4 in THF gave the expected amino 
(trifluoromethyl)alcohols 2a,b in 69 and 78% yield, respectively. 
Another approach suitable for the preparation of amino alcohols with a primary amino 
group is the debenzylation of the initially obtained secondary N-benzylated amines 2. 
Especially important in this case is the exploration of N-(α-methylbenzyl) derivatives, 
which opens access to optically active amino alcohols. The preparation of optically 
active amino alcohols 2c,d, synthesized from (S)-α-methylbenzylamine and arylglyoxal 
hydrates 5a,b, has already been reported [5]. The separated diastereoisomers were 
treated with H2/Pd, C in methanol at room temperature to give the enantiomerically pure 
amino alcohols (R)-2a, (S)-2a, (R)-2b, and (S)-2b (Scheme 4). 
 
 
Scheme 4 
 
The enantiomeric purity of the obtained chiral amino alcohols (R)- and (S)-2a and (R)- 
and (S)-2b was established spectroscopically by running the 1H- and 19F-NMR spectra 
in CDCl3 in the presence of the optically pure (S)-(tert-butyl)(phenyl)phosphonothioic 
acid [9] (see also [5,7f,10]. 
The synthesis of imidazoles was carried out first with racemic amino alcohols 2a and 2b 
using formaldehyde and diacetyl monooxime (4a). After heating the mixture in boiling 
ethanol for 3h, imidazole N-oxides 3a and 3b were isolated in 70 and 82% yield, 
respectively (Scheme 5).  
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Scheme 5 
 
On the other hand, the same procedure applied for 2b and ethyl 2-hydroxyimino-3-
oxobutanoate (4b) led to imidazolone 8a, which was obtained as the sole product 
(Scheme 6). Based on our earlier observation, the formation of 8a in this case can be 
rationalized by the isomerisation of the initially formed N-oxide 3c.  
 
 
 
Scheme 6 
 
In general, 2-unsubstituted imidazole N-oxides bearing an electron withdrawing 
substituent at C(4) tend to undergo spontaneous isomerization to the corresponding 
imidazolones already at room temperature [10]. Otherwise, the isomerization requires 
heating of the N-oxide [11a], irradiation with UV light [11b], or treatment with acetic 
anhydride [7b]. The experiment with 4b and 2b was repeated in ether at room 
temperature, but also in this case only 8a was obtained. Similarly, the reaction 
performed with 3-hydroxyiminopentane-2,4-dione (4c) led to imidazolone derivative 8b 
(Scheme 6). 
Finally, the enantiomerically pure amino alcohols (S)-2a and (S)-2b were used in the 
reaction with formaldehyde and 4a in boiling ethanol. The optically active imidazole N-
oxides (S)-3a and (S)-3b were isolated in 52 and 50% yield.  
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3. Conclusions 
 
The presented results show that properly substituted imino derivatives of arylglyoxals 
can be used for the nucleophilic trifluoromethylation with the Ruppert-Prakash reagent 
and subsequent treatment with LiAlH4 or reduction/debenzylation lead to β-amino-α-
trifluoromethyl alcohols possessing a primary amino group. The 
reduction/debenzylation procedure with the imine derived from enantiomerically pure 
(S)-α-methylbenzylamine opens a convenient access to enantiomerically pure 
trifluoromethylated amino alcohols. Both racemic and enantiomerically pure amino 
alcohols 2 can be used as new building blocks for the preparation of imidazole 
derivates. Depending on the substitution pattern of α-hydroxyimino ketone used in 
these reactions, either 2-unsubstituted imidazole N-oxides or the isomeric imidazol-2-
ones were obtained. The structure of the obtained imidazole derivatives relates to some 
known biologically active compounds and, therefore, they may be of interest for future 
applications. 
 
4. Experimental part 
 
4.1. General experimental procedures 
 
General: Melting points were determined on a Melt-Temp. II apparatus (Aldrich) in 
capillary and they are uncorrected. The 1H, 13C{1H} and 19F NMR spectra were 
recorded on Bruker Avance III 600 or Varian Gemini BB 200 spectrometers using 
solvent signals as reference. Assignments of signals in 13C NMR spectra were made on 
the basis of HMQC experiments. The IR spectra were measured using an NEXUS FT-
IR spectrophotometer. The MS spectra (ESI, ESI-HRMS) were obtained using Varian 
500-MS or Bruker Esquire LC spectrometers. Elemental analyses were performed in the 
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PAS in Łódź. Optical rotations were measured on a PERKIN-ELMER 241 MC 
spectropolarimeter for λ = 589 nm. 
 
4.2. Materials 
 
Commercial paraformaldehyde, (trifluoromethyl)trimethylsilane, methoxyamine 
hydrochloride, lithiumaluminium hydride (1M solution in THF) and palladium on 
charcoal (10%) were purchased from Sigma-Aldrich. α-(Hydroxyimino)ketones 4a 
[12a], 4b [12b], and 4c [12c], as well as 2,2-dihydroxy-1-arylethanones 5a,b [13] were 
prepared according to known protocols. (2R/2S,1’S)-1,1,1-Trifluoro-3-[1-(1-
phenylethylamino)]-2-arylpropan-2-ols 2c,d were prepared according to the published 
procedure [5]. Dimethoxyethane (DME) and tetrahydrofurane (THF) were dried over 
sodium with benzophenone and they were freshly distilled prior to their use.  
 
4.3. Syntheses of α-(methoxyimino)ketones 6 
 
General procedure. 1-Aryl-2,2-dihydroxyethanone 6a,b (5 mmol), methoxyamine 
hydrochloride (5.05 mmol), and sodium acetate were dissolved in MeOH/H2O 4:1 (10 
ml). The mixture was gently heated to reflux for 30 min. Then, the mixture was diluted 
with a saturated aqueous solution of NaHCO3 and extracted with CH2Cl2. The combined 
organic layers were dried over anhydrous Na2SO4. After filtration, the solutions were 
evaporated to dryness (room temperature bath). Products 6, contaminated with ca. 5% 
(by 1H NMR) of unidentified impurities, were used for further transformations without 
purification. 
 
2-(Methoxyimino)-1-phenylethanon (6a). Yield: 0.73 g (90%). Pale yellow oil. 1H NMR 
(600 MHz, CDCl3): δ 4.10 (s, 3H, CH3O), 7.45–7.49 (m, 2 arom. CH), 7.58–7.63 (m, 1 
arom. CH), 7.95 (s, 1H, HC=N), 8.07–8.09 (m, 2 arom. CH). 13C NMR (150 MHz, 
CDCl3): δ 63.4 (CH3O), 128.3, 130.1, 133.4 (5 arom. CH), 135.9 (1 arom. C), 147.1 
(HC=N), 188.1 (C=O). IR (film): v 3061w, 2979m, 2900w, 2822w, 1656vs (C=O), 
1598s (C=N), 1448s, 1328s, 1278s, 1233m, 1182m, 1036s, 1020s, 926m cm–1. 
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2-(Methoxyimino)-(4-methoxyphenyl)ethanon (6b). Yield: 0.89 g (92%). Pale yellow 
oil. 1H NMR (200 MHz, CDCl3): δ 3.89, 4.09 (2s, 6H, 2 CH3O), 6.94–6.98 (m, 2 arom. 
CH), 7.94 (s, 1H, HC=N), 8.10–8.15 (m, 2 arom. CH). 13C NMR (50 MHz, CDCl3): δ 
55.1, 62.9 (2 CH3O), 113.5, 132.2 (4 arom. CH), 128.5, 146.9 (2 arom. C), 163.8 
(HC=N), 185.9 (C=O). IR (film): v 3073w, 3000w, 2944w, 1640vs (C=O), 1604vs 
(C=N), 1511m, 1424w, 1293s, 1260vs, 1186m, 1177m, 1037s, 839s cm–1. 
 
4.4. Synthesis of β-amino-α-trifluoromethyl alcohols 2 
4.4.1. Reactions of α-iminoketones 6a,b with (trifluoromethyl)trimethylsilane – general 
procedure. A solution of the corresponding α-methoxyimino ketone 6a,b (1 mmol) in 
anhydrous DME (1.5 ml), was placed in a dry, two-necked flask, equipped with septum 
and a tube filled with anhydrous CaCl2. Next, a catalytic amount (3–5 mg) of freshly 
dried CsF and (trifluoromethyl)trimethylsilane (0.17 ml, 157 mg, 1.1 mmol) were 
added. The mixture was stirred at room temperature for ca. 1 h and subsequently 
quenched with water (5 ml). The solution was extracted with CH2Cl2 three times. The 
organic layers were combined and dried over anhydrous Na2SO4. After filtration, the 
solvents were evaporated and the crude, oily products 7a,b were used for further 
reactions without purification. 
 
4.4.2. Reduction of adducts 7a,b with lithium aluminium hydride – general procedure. 
To a magnetically stirred solution of the corresponding adduct 7a,b in anhydrous THF 
(3 ml), 1M solution of LiAlH4 (1.0 ml, 1 mmol) was added dropwise while cooling, and 
the mixture was stirred for 12 h at room temperature. After this time, a portion of water 
(ca. 5 ml) was added carefully while cooling the reaction flask in an ice-bath. Next, a 
solution of saturated aqueous NaOH and solid KOH were added, and subsequently the 
products were extracted with Et2O. The organic layers were combined and dried over 
anhydrous Na2SO4. After filtration, the solvents were evaporated and the crude products 
were purified by column chromatography on SiO2. 
 
3-Amino-1,1,1-trifluoro-2-phenylpropan-2-ol ((rac)-2a). Yield: 141 mg (69%). 
Colourless crystals, m.p. 84–86 ºC (hexane). 1H NMR (600 MHz, CDCl3): δ 2.71 (br. s, 
2H, OH, NH), 3.04, 3.52 (2d, 2JH,H = 13.2 Hz, 2H, CH2), 7.35–7.41 (m, 3 arom. CH), 
7.58–7.59 (m, 2 arom. CH). 13C NMR (150 MHz, CDCl3): δ 45.7 (CH2), 74.3 (q, 2JC,F = 
27.2 Hz, Cq), 126.0 (q, 1JC,F = 285.3 Hz, CF3), 126.4, 128.5, 128.7 (5 arom. CH), 137.6 
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(1 arom. C). 19F NMR (565 MHz, CDCl3): δ –78.3 (s, CF3). IR (KBr): v 3388s (O–H), 
3095m, 3068m, 2904m, 1603w, 1458m, 1273m, 1196s, 1163vs, 1152vs, 1071m, 942m 
cm–1. ESI-MS m/z (rel. int.): 206 (45, [M+1]+), 188 (100, [M–18+1]+). Anal. Calcd for 
C9H10F3NO (205.18): C, 51.07; H, 5.14. Found: C, 50.79; H, 5.14. 
 
3-Amino-1,1,1-trifluoro-2-(4-methoxyphenyl)propan-2-ol ((rac)-2b). Yield: 183 mg 
(78%). Colourless crystals, m.p. 94–96 ºC (hexane/Et2O). 1H NMR (600 MHz, CDCl3): 
δ 3.03, 3.51 (2d, 2JH,H = 13.2 Hz, 2H, CH2), 3.82 (s, 3H, CH3O), 6.92–6.93 (m, 2 arom. 
CH), 7.49–7.51 (m, 2 arom. CH). 13C NMR (150 MHz, CDCl3): δ 45.6 (CH2), 55.5 
(CH3O), 73.9 (q, 2JC,F = 27.2 Hz, Cq), 113.9, 127.7 (4 arom. CH), 126.0 (q, 1JC,F = 286.8 
Hz, CF3), 129.6, 159.9 (2 arom. C). 19F NMR (565 MHz, CDCl3): δ –78.7 (s, CF3). IR 
(KBr): v 3342s (O–H), 3312m (N–H), 3017m, 2972m, 2913m, 1692w, 1515s, 1465m, 
1305m, 1254s, 1183s, 1154vs, 1112m, 1036m, 960m cm–1. ESI-MS m/z (rel. int.): 236 
(27, [M+1]+), 218 (100, [M–18+1]+). Anal. Calcd for C10H12F3NO2 (235.21): C, 52.69; 
H, 4.91. Found: C, 52.68; H, 4.95. 
 
4.4.3. Hydrogenolysis of β-amino-N-phenylethyl-α-trifluoromethyl alcohols 2c,d 
 
To a solution of the corresponding amino alcohol (2S,1’S)- or (2R,1’S)-2c,d (1.0 mmol) 
in MeOH (2 ml), 10% Pd/C (150 mg) was added, and the flask was closed with a 
septum. Then, hydrogen was bubbled through the mixture via a needle from a rubber 
balloon, and the suspension was stirred for ca. 3 h under atmospheric pressure. Next, the 
solvent was evaporated under vacuum, and the products were isolated after filtration 
through cellite and silica gel pads using a mixture hexane/CH2Cl2 (1:1) as the eluent.  
 
(S)-3-Amino-1,1,1-trifluoro-2-phenylpropan-2-ol ((S)-2a). Yield: 189 mg (92%). 
Colourless crystals, m.p. 86–88 ºC (hexane), [α]D = +43 (c 1.0, CH2Cl2). Spectroscopic 
data identical with data for (rac)-2a. 
 
(R)-3-Amino-1,1,1-trifluoro-2-phenylpropan-2-ol ((R)-2a). Yield: 185 mg (90%). 
Colourless crystals, m.p. 84–86 ºC (hexane), [α]D = –42 (c 1.0, CH2Cl2). Spectroscopic 
data identical with data for (rac)-2a. 
 
(S)-3-Amino-1,1,1-trifluoro-2-(4-methoxyphenyl)propan-2-ol ((S)-2b). Yield: 190 mg 
(81%). Colourless crystals, m.p. 97–99 ºC (hexane/Et2O), [α]D = +28 (c 1.0, CH2Cl2). 
Spectroscopic data identical with data for (rac)-2b. 
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(R)-3-Amino-1,1,1-trifluoro-2-(4-methoxyphenyl)propan-2-ol ((R)-2b). Yield: 181 mg 
(77%). Colourless crystals, m.p. 98–100 ºC (hexane/Et2O). [α]D = –29 (c 1.0, CH2Cl2). 
Spectroscopic data identical with data for (rac)-2b. 
 
4.5. Syntheses of imidazole derivatives 3 and 8 
 
4.5.1. Reactions of β-amino-α-trifluoromethyl alcohols 2a,b with paraformaldehyde and 
α-(hydroxyimino)ketone 4a – general procedure. A solution of a β-amino-α-
trifluoromethyl alcohol 2a,b (1.0 mmol) and paraformaldehyde (32 mg, 1.05 mmol) in 
EtOH was stirred at room temperature for 12 h. The solution was filtered, α-
(hydroxyimino)ketone 4a (1.1 mmol) was added, and the mixture was heated to reflux 
for 6 h. Then, the solvent was evaporated, the residue was treated with Et2O, and the 
crystalline product was separated and washed several times with Et2O. Pure products 
were obtained after crystallization from an appropriate solvent. 
 
3-(4,5-Dimethyl-3-oxido-1H-imidazol-1-yl)-2-phenyl-1,1,1-trifluoropropan-2-ol ((rac)-
3a). Yield: 210 mg (70%). Colourless crystals, m.p. 239–241 ºC (decomp.; 
iPr2O/MeOH). 1H NMR (600 MHz, CD3OD): δ 1.96, 2.06 (2s, 6H, 2 CH3), 4.55 (s, 2H, 
CH2), 7.41–7.44 (m, 3 arom. CH), 7.55–7.57 (m, 2 arom. CH), 7.78 (s, 1 CH imidazol). 
13C NMR (150 MHz, CDCl3): δ 5.5, 7.1 (2 CH3), 49.6 (CH2), 76.6 (q, 2JC,F = 27.4 Hz, 
Cq), 123.2, 124.8, 135.0 (2 C imidazole, 1 arom. C), 125.2 (q, 1JC,F = 285.4 Hz, CF3), 
126.1, 128.3, 129.0 (5 arom. CH), 126.6 (1 CH imidazol). 19F NMR (565 MHz, 
CD3OD): δ –75.6 (s, CF3). IR (KBr): v 3153br.m, 3061br.m, 2930w, 2630br.m, 1632w, 
1450m, 1444w, 1404m, 1341m, 1267s, 1250s, 1172vs, 1155vs, 1079m, cm–1. ESI-
HRMS: Calcd for C14H15F3N2O2Na+ ([M+23]+): m/z 323.09783; found: m/z 323.09778. 
Calcd for C14H16F3N2O2+ ([M+1]+): m/z 301.11584; found: m/z 301.11606. 
 
(S)-3-(4,5-Dimethyl-3-oxido-1H-imidazol-1-yl)-2-phenyl-1,1,1-trifluoropropan-2-ol 
((S)-3a). Yield: 190 mg (63%). Colourless crystals, m.p. 240–242 ºC (decomp.; 
iPr2O/MeOH). [α]D = +16.0 (c 1.0, MeOH). Spectroscopic data identical with data for 
(rac)-3a. 
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3-(4,5-Dimethyl-3-oxido-1H-imidazol-1-yl)-1,1,1-trifluoro-2-(4’’-methoxyphenyl)-
propan-2-ol ((rac)-3b). Yield: 271 mg (82%). Colourless crystals, m.p. 235–237 ºC 
(decomp.; iPr2O/MeOH). 1H NMR (600 MHz, CD3OD): δ 1.93, 2.04 (2s, 6H, 2 CH3), 
3.80 (s, CH3O), 4.49 (s, 2H, CH2), 6.93–6.96, 7.43–7.44 (2m, 4 arom. CH), 7.72 (s, 1 
CH imidazol). 13C NMR (150 MHz, CD3OD): δ 7.1, 8.7 (2 CH3), 51.1 (CH2), 55.9 
(CH3O), 78.0 (q, 2JC,F = 27.5 Hz, Cq), 115.2, 129.0 (4 arom. CH), 128.1 (1 CH 
imidazol), 126.8 (q, 1JC,F = 285.3 Hz, CF3), 125.2, 125.3, 126.3, 162.0 (2 C imidazole, 2 
arom. C). 19F NMR (565 MHz, CD3OD): δ –77.9 (s, CF3). IR (KBr): v 3162br.m, 
3018br.m, 2845br.w, 2614br.w, 1613m, 1516s, 1444w, 1340w, 1305m, 1250s, 1173vs, 
1154vs, 1030m, 841m cm-1. ESI-HRMS: Calcd for C15H18F3N2O3+ ([M+1]+): m/z 
331.12640; found: m/z 331.12662. 
 
(S)-3-(4,5-Dimethyl-3-oxido-1H-imidazol-1-yl)]-1,1,1-trifluoro-2-(4-
methoxyphenyl)propan-2-ol N-oxide ((S)-3b). Yield: 202 mg (61%). Colourless 
crystals, m.p. 234–236 ºC (decomp.; iPr2O/MeOH). [α]D = +13.7 (c 1.0, MeOH). 
Spectroscopic data identical with data for (rac)-3b. 
 
Reactions of β-amino-α-trifluoromethyl alcohol 2b with paraformaldehyde and 
α-(hydroxyimino)ketones 4b,c – general procedure. A solution of a β-amino-α-
(trifluoromethyl)alcohol 2a,b (1.0 mmol) and paraformaldehyde (32 mg, 1.05 mmol) in 
EtOH was stirred at room temperature for 12 h. Then, the solution was filtered, 4b or 4c 
(1.1. mmol) was added, and the mixture was stirred in room temperature for 48 h. The 
white precipitate was filtered off and washed several time with Et2O.  
 
3-(4-Ethoxycarbonyl-2,3-dihydro-5-methyl-2-oxo-1H-imidazol-1-yl)-1,1,1-trifluoro-2-
(4-methoxyphenyl)propan-2-ol ((rac)-8a). Yield: 125 mg (30%). Colourless crystals, 
m.p. 196–198 ºC (decomp.). 1H NMR (600 MHz, DMSO-d6): δ 1.23 (t, 3JH,H = 7.2 Hz, 
3H, CH3CH2), 2.22 (s, 3H, CH3), 3.76 (s, CH3O), 4.17 (t, 3JH,H = 7.2 Hz, 3H, CH3CH2), 
4.21, 4.32 (2d, 2H, 2JH,H = 15.6 Hz, 2H, CH2), 6.95–6.96, 7.52–7.54 (2m, 4 arom. CH), 
7.58 (s, 1H, OH), 10.92 (s, 1H, NH). 13C NMR (150 MHz, DMSO-d6): δ 9.9 (CH3), 
14.2 (CH3CH2), 46.7 (CH2), 55.1 (CH3O), 60.0 (CH3CH2), 76.7 (q, 2JC,F = 27.4 Hz, Cq), 
125.3 (q, 1JC,F = 286.8 Hz, CF3), 113.6, 128.1 (4 arom. CH), 127.7, 127.9 131.5, 154.6 
(2 C imidazole, 2 arom. C), 159.5 (CH3CH2CO2 and C=O). 19F NMR (565 MHz, 
DMSO-d6): δ –76.4 (s, CF3). IR (KBr): v 3280br.s (N–H + O–H), 1693vs (C=O), 
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1636vs (C=O), 1605s, 1514m, 1443m, 1308m, 1254m, 1180s, 1173vs, 1153vs, 1144s, 
1111m, 1029m cm–1. ESI-HRMS: Calcd for C17H19F3N2O5Na+ ([M+23]+): m/z 
411.11383; found: m/z 411.11384. 
 
3-(4-Acetyl-2,3-dihydro-5-methyl-2-oxo-1H-imidazol-1-yl)-1,1,1-trifluoro-(4-
methoxphenyl)propan-2-ol ((rac)-8b). Yield: 155mg (40%). Colourless crystals, m.p. 
222–225 ºC (decomp.). 1H NMR (600 MHz, DMSO-d6): δ 2.25, 2.26 (2s, 6H, CH3 + 
CH3CO), 3.76 (CH3O), 4.23, 4.35 (2d, 2H, 2JH,H = 15.0 Hz, 2H, CH2), 6.95–6.97, 7.53–
7.55 (2m, 4 arom. CH), 7.51 (s, 1 H, OH), 10.89 (s, 1H, NH). 13C NMR (150 MHz, 
DMSO-d6): δ 10.5 (CH3), 28.1 (CH3CO), 46.3 (CH2), 55.1 (CH3O), 76.6 (q, 2JC,F = 27.2 
Hz, Cq), 125.2 (q, 1JC,F = 288.3 Hz, CF3), 113.5, 127.6 (4 arom. CH), 118.8, 127.5, 
131.2, 153.7 (2 C imidazole, 2 arom. C), 159.4 (C=O), 186.6 (CH3CO). 19F NMR (565 
MHz, DMSO-d6): δ –76.1 (s, CF3). IR (KBr): v 3280br.s (N–H + O–H), 1693vs (C=O), 
1636vs (C=O), 1605s, 1514m, 1443m, 1308m, 1254m, 1180s, 1173vs, 1153vs, 1144s, 
1111m, 1029m, cm-1. ESI-HRMS: Calcd for C16H17F3N2O4Na+ ([M+23]+): m/z 
381.10326; found: m/z 381.10346. 
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